Latest News about RHHBY
Recent news which mentions RHHBY
Tempest Therapeutics shares head back to earth after 4,000% gain
October 12, 2023
From MarketWatch
TPST Stock: 7 Things to Know About Tempest Therapeutics
October 11, 2023
From InvestorPlace
From Benzinga
From MarketWatch
From Benzinga
From InvestorPlace
2 Cathie Wood Stocks That Could Deliver Exponential Returns
October 02, 2023
From Motley Fool
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
September 27, 2023
From Benzinga
AI To Revolutionize Clinical Trials And Diagnostics
September 22, 2023
From Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
From Benzinga
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
September 13, 2023
From InvestorPlace
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street
September 12, 2023
From Motley Fool
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
From Benzinga
Recursion Pharmaceuticals has a prescription for high drug costs: AI and 25 petabytes of data
September 08, 2023
From MarketWatch
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
September 07, 2023
From Benzinga
Roche's Approved Lung Cancer Drug Beats Chemo In Rare Type Of Lung Cancer
September 01, 2023
From Benzinga
Cancer Treatment In 7 Minutes: UK's Health Service To Rollout Roche's Tencentriq Injection Cutting Treatment Time
August 30, 2023
From Benzinga
3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List
August 28, 2023
From InvestorPlace
From Benzinga
Roche's Accidental Lung Cancer Trial Data Leak: Shows Encouraging Early Data From Combination Therapy Study
August 23, 2023
From Benzinga
Regeneron's Crucial Eylea HD Approval: A Shield Against Potential Biosimilar Competition?
August 21, 2023
From Benzinga
Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
August 21, 2023
From Benzinga
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
August 21, 2023
From Motley Fool
What's Going On With Sonnet BioTherapeutics Stock Today?
August 16, 2023
From Benzinga
Is TTOO Stock Really Worth $5? Or Just 5 Cents?
August 09, 2023
From InvestorPlace
Is AbbVie Still a Good Dividend Stock to Buy?
August 08, 2023
From Motley Fool
Why Is Aravive Stock Sinking Today?
August 03, 2023
From Benzinga
Johnson & Johnson, Other Pharma Makers Anticipate Reformulated Injectable Drugs May Exclude Price Negotiations
July 28, 2023
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.